NTRA
NTRA
US6323071042
Natera, Inc.
Loading chart...

Company Profile

-

Related stocks

IDXX
IDXX • United States
IDEXX Laboratories, Inc.
518 USD
40.86B USD 1Y -18.5%
ILMN
ILMN • United States
Illumina, Inc.
278.17 USD
42B USD 1Y +170.6%
A
A • United States
Agilent Technologies, Inc.
170.54 USD
48.08B USD 1Y +19.4%
IQV
IQV • United States
IQVIA Holdings, Inc.
259.88 USD
42.78B USD 1Y +29.1%
WAT
WAT • United States
Waters Corporation
433.77 USD
42.59B USD 1Y +31%
GH
GH • United States
Guardant Health, Inc.
167.47 USD
22.47B USD 1Y +153.5%
CRL
CRL • United States
Charles River Laboratories Inte
301.79 USD
14.41B USD 1Y +71.8%
MEDP
MEDP • United States
Medpace Holdings, Inc.
612.05 USD
17.08B USD 1Y +13.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country
United States
Region
North America
Sector
Healthcare
Industry
Diagnostics & Research

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
57.6% p.a.
Max Drawdown (5Y)
-76.4%
Sharpe Ratio (5Y)
0.44
Beta Factor
1.50
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (57.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -77.7% in the extended horizon.
ende